News from sangamo biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 08, 2014, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad Application of ZFN Mediated Genome-Editing Approach to Therapeutics for Hemophilia and Lysosomal Storage Disorders

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new preclinical data from its proprietary programs for the treatment of...

Nov 19, 2014, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that positive preclinical data from its joint program with Shire plc, to develop a novel ZFP...

Nov 10, 2014, 09:05 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences President and CEO Edward Lanphier to Serve as Chairman of the Alliance for Regenerative Medicine

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Edward Lanphier, the Company's president and CEO, has been elected to serve as the next...

Oct 22, 2014, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Reports Third Quarter 2014 Financial Results

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its third quarter 2014 financial results and accomplishments. For the third quarter...

Oct 16, 2014, 07:00 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Company scientists and clinicians, as well as academic collaborators, were invited...

Oct 15, 2014, 16:02 ET
Sangamo BioSciences, Inc.

Sangamo BioSciences Announces Third Quarter 2014 Conference Call and Webcast

Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its third quarter 2014 financial results after the market...

Sep 10, 2014, 07:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Target Date For First IND For Sangamo's In Vivo ZFN Genome-Editing Platform For Monogenic Diseases

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced plans to submit an Investigational New Drug (IND) application for the treatment of hemophilia B...

Sep 08, 2014, 07:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV-Infected Subjects Treated with SB-728-T

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new data demonstrating that a single infusion of Sangamo's novel ZFP...

Sep 03, 2014, 16:02 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation at the 2014 Morgan Stanley Global Healthcare Conference

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress...

Aug 05, 2014, 16:02 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At The 2014 Wedbush Securities Life Sciences Management Access Conference

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president of research and...

Aug 05, 2014, 08:30 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Five Sangamo Scientists Recognized By Thomson Reuters Among Most Highly Cited Researchers Worldwide Of 2014

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that five members of the Company's research and development team were recently named among...

Jul 23, 2014, 16:02 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Reports Second Quarter 2014 Financial Results

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its second quarter 2014 financial results and accomplishments. For the second...

Jul 16, 2014, 16:02 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Second Quarter 2014 Conference Call And Webcast

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its second quarter 2014 financial results after the...

Jun 19, 2014, 07:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Appoints H. Stewart Parker to its Board of Directors

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the appointment of H. Stewart Parker to the Company's Board of Directors. Ms. Parker, who...

Jun 17, 2014, 16:05 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At The 2014 JMP Securities Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO,...

May 30, 2014, 07:05 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences And City of Hope Granted Strategic Partnership Award From California Institute for Regenerative Medicine To Support Clinical Trial Of Stem-Cell Based ZFP Therapeutic® For HIV/AIDS

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million...

May 29, 2014, 18:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At The Jefferies 2014 Global Healthcare Conference

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress...

May 28, 2014, 13:34 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Publication of Preclinical Data Demonstrating Gene Correction in SCID-X1 Human Hematopoietic Stem Cells

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication in Nature of data demonstrating efficient zinc finger nuclease...

May 27, 2014, 07:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Provides Clinical Update on SB-728-T Program and Progress in Other ZFP Applications at Annual Meeting of the American Society of Gene and Cell Therapy

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that data from clinical, preclinical and research-stage programs focused on the...

May 15, 2014, 16:05 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At The UBS Global Healthcare Conference

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president, research and...